Form 8-K - Current report:
SEC Accession No. 0001193125-24-283105
Filing Date
2024-12-20
Accepted
2024-12-20 16:06:00
Documents
15
Period of Report
2024-12-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d882575d8k.htm   iXBRL 8-K 27066
2 EX-5.1 d882575dex51.htm EX-5.1 9894
6 GRAPHIC g882575g1219073508451.jpg GRAPHIC 2534
  Complete submission text file 0001193125-24-283105.txt   171067

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA calc-20241220.xsd EX-101.SCH 2878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20241220_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20241220_pre.xml EX-101.PRE 11726
18 EXTRACTED XBRL INSTANCE DOCUMENT d882575d8k_htm.xml XML 3805
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 241567947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)